Gilead’s Coronavirus Treatment Has Investors Excited, but the Latest Study Looks Inconclusive
On Thursday, STAT News reported positive results from a clinical trial of remdesivir (RDV), a potential antiviral treatment for the…
On Thursday, STAT News reported positive results from a clinical trial of remdesivir (RDV), a potential antiviral treatment for the…
The world’s largest meat-processing giant was forced to shut down some of its US plants as more than 100 of…
Opinion banner Business Insider SARS-CoV2 vaccines will not be realistically available for another 12-18 months, says Guido Vanham. Francois Mori/AP…
CHICAGO — President Donald Trump on Friday announced a $19 billion relief program to help U.S. farmers cope with the…
By Gavin Jones and Angelo Amante ROME (Reuters) – Deaths from the COVID-19 epidemic in Italy rose by 575 on…
RIO DE JANEIRO — Brazil’s President Jair Bolsonaro, whose dismissive stance toward the COVID-19 pandemic has angered many health experts,…
WASHINGTON – Sen. Mitt Romney, the sole Republican who voted to convict President Donald Trump in his impeachment trial, was the only…
Millions of Americans — especially those who use income tax preparers such as H&R Block and TurboTax — are still…
By Sanjeev Miglani and Aftab Ahmed NEW DELHI, April 16 (Reuters) – India has brought charges of culpable homicide not…
More than 900 staffers at New York City’s public hospital system have tested positive for the coronavirus and 3,000 have…